Comparative study of non nucleoside inhibitors with HIV-1 reverse transcriptase based on 3D-QSAR and docking

SAR and QSAR in Environmental Research

Volumn 14, Issue 5-6, 2003, Pages 455-474

  Chen, H F ^a,b   Yao, X J ^a   Li, Q ^b   Yuan, S G ^b   Panaye, A ^a   Doucet, J P ^a   Fan, B T ^a  

^a UNIVERSITÉ PARIS DIDEROT   (France)

^b SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY   (China)

Author keywords

3D QSAR; HIV 1 reverse transcriptase; Interaction mechanism; Non nucleoside inhibitors

Indexed keywords

BIOMOLECULES; COMPUTATIONAL CHEMISTRY; HYDROPHOBICITY; MOLECULAR GRAPHICS;

3D-QSAR; COMPARATIVES STUDIES; DOCKING STUDIES; HIV-1 REVERSE TRANSCRIPTASE; INTERACTION MECHANISMS; INTERMOLECULAR INTERACTIONS; MIXED MODELING; NON NUCLEOSIDE INHIBITOR; NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS; REVERSE-TRANSCRIPTASE;

HYDROGEN BONDS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0344553473     PISSN: 1062936X     EISSN: None     Source Type: Journal    
DOI: 10.1080/10629360310001624033     Document Type: Conference Paper

References (39)

1. Hopkins, A.L., Ren, J.S., Esnouf, R.M., Willcox, B.E., Jones, E.Y., Ross, C., Miyasaka, T., Walker, R.T., Tanaka, H., Stammers, D.K. and Stuart, D.I. (1996) "Complex of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent", J. Med. Chem. 39, 1589-1600.
2. Wang, J.M., Morin, P., Wang, W. and Kollman, P.A. (2001) "Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA", J. Am. Chem. Soc. 123, 5221-5230.
3. Mitsuya, H., Weinhold, K.J., Furman, P.A., St. Clair, M.H., Nusinoff, L.S., Gallo, R.C., Bolognesi, D., Barry, D.W. and Broder, S. (1985) "3′-Azido-3′-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effects of human T-lymphotrophic virus type III/lymphadenopathy-associated virus in vitro", Proc. Natl Acad. Sci. USA 82, 7096-7100.
4. Mitsuya, H. and Broder, S. (1986) "Inhibition of in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lympadenopathy-associated virus (HTLV-III/LVA) by 2′,3′- dideoxynucleosides", Proc. Natl Acad. Sci. USA 83, 1911-1915.
5. Yarchoan, R., Mitsuya, H., Thomas, R.V., Pluda, J.M., Hartman, N.R., Perno, C.F., Marczyk, K.S., Allain, J.P., Johns, D.G. and Broder, S. (1989) "In vivo activity against HIV and favourable toxicity profile of 2′,3′-dideoxyinosine", Science 245, 412-415.
6. Coates, J.A.V., Cammack, N., Jenkinson, H.J., Mutton, I.M., Pearson, B.A., Storer, R., Cameron, J.M. and Penn, C.R. (1992) "The separated enantiomers of 2′-deoxy-3′-thiacytidine (BCH-189) both inhibit human immunodeficiency virus replication in vitro", Antimicrob. Agents Chemother. 36, 202-205.
7. De Clercq, E. (1993) "HIV-1 specific RT inhibitors: highly selective inhibitors of human immunodeficiency virus type 1 that are specifically targeted at the viral reverse transcriptase", Med. Res. Rev. 13, 229-258.
8. Kireev, D.B., Chretien, J.R., Grierson, D.S. and Monneret, C. (1997) "A 3D QSAR study of a series of HEPT analogues: the influence of conformational mobility on HIV-1 reverse tanscriptase inhibition", J. Med. Chem. 40, 4257-4264.
9. Eriksson, M.A.L., Pitera, J. and Kollman, P.A. (1999) "Prediction of the binding free energies of new TIBO-like HIV-1 reverse transcriptase inhibitors using a combination of PROFEC, PB/SA, CMC/MD, and free energy calculations", J. Med. Chem. 42, 868-881.
10. Huuskonen, J. (2001) "QSAR modeling with the electrotopological state: TIBO derivatives", J. Chem. Inf. Comput. Sci. 41, 425-429.
11. HeravI, M.J. and Parastar, F. (2000) "Use of artificial neural networks in a QSAR study of anti-HIV activity for a large group of HEPT derivatives", J. Chem. Inf. Comput. Sci. 40, 147-154.
12. Barrios, F.R., Perez, C., Lobaton, E., Velazquez, S., Chamorro, C., Felix, A.S., Perez, P.M.J., Camarasa, M.J., Pelemans, H., Balzarini, J. and Gago, F. (2001) "Identification of a putative binding site for [2′,5′-bis-o-(tert-butyldimethylsilyl)-α-D-ribofuranosyl] -3′-spiro-5″-(4″-amino-1″,2″-oxathiole-2″, 2″-dioxide)thymine(TSAO) derivaties at the p51-p66 interface of HIV-1 reverse transcriptase", J. Med. Chem. 44, 1853-1865.
13. Rizzo, R., Rives, J.T. and Jorgenson, W.L. (2001) "Estimation of binding affinities for HEPT and nevirapine analogues with HIV-1 reverse transcriptase via Monte Carlo simulations", J. Med. Chem. 44, 45-154.
14. Rizzo, R.C., Blagovic, M.U., Wang, D.P., Watkins, E.K., Smith, M.B.K., Smith, R.H., Rives, J.T. and Jorgensen, W.L. (2002) "Prediction of activity for nonnucleoside inhibitors with HIV-1 reverse transcriptase based on Monte Carlo simulations", J. Med. Chem. 45, 2970-2987.
15. Morris, G.M., Goodsell, D.S., Heuey, R., Hart, W.E., Halliday, S., Belew, R. and Olson, A.J. (1999) Autodock version 3.03. The scripps research Institute, Molecular Graphics Laboratory, Department of Molecular Biology.
16. Morris, G.M., Goodsell, D.S., Halliday, R.S., Heuey, R., Hart, W.E., Belew, R.K. and Olson, A.J. (1998) "Automated docking using Lamarckian genetic algorithm and empirical binding free energy function", J. Comput. Chem. 19, 1639-1662.
17. Kua, J., Zhang, Y.K. and McCammon, J.A. (2002) "Studing enzyme binding specificity in acetylcholinesterase using a combined molecular dynamics and multiple docking approach", J. Am. Chem. Soc. 124, 8260-8267.
18. Esnouf, R., Ren, J.S., Ross, C., Jones, Y., Stammers, D. and Stuart, D. (1995) "Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors", Nature Struct. Biol. 2, 303-308.
19. Chen, M., Sudbeck, E.A., Venkatachalam, T.K. and Uckun, F.M. (2000) "Structure-based drug design of non-nucleoside inhibitors for wild-type and drug-resistant HIV reverse transcriptase", Biochem. Pharmacol. 60, 1251-1265.
20. Tanaka, H., Baba, M., Hayakawa, H., Sakamaki, T., Miyasaka, T., Ubasawa, M., Takashima, H., Sekiya, K., Nitta, I., Shigeta, S., Walker, R.T., Balzarini, J. and De Clercq, E. (1991) "A new class of HIV-1-specific 6-substituted acyclouridine derivatives: synthesis and anti-HIV-1 activity of 5-or 6-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT)", J. Med. Chem. 34, 349-357.
21. Miyasaka, T., Tanaka, H., Baba, M., Hayakawa, H., Walker, R.T., Balzarini, J. and De Clercq, E. (1989) "A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine", J. Med. Chem. 32, 2507-2509.
22. Baba, M., Tanaka, H., De Clercq, E., Pauwels, R., Balzarini, J., Schols, D., Nakashima, H., Perno, C.F., Walker, R.T. and Miyasaka, T. (1989) "Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative", Biochem. Biophys. Res. Commun. 165, 1375-1381.
23. Tanaka, M., Baba, M., Ubasawa, M., Takashima, H., Sekiya, K., Nitta, I., Shigeta, S., Walker, R.T., De Clercq, E. and Miyasaka, T. (1991) "Synthesis and anti-HIV activity of 2-, 3-, and 4-substituted analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT)", J. Med. Chem. 34, 1394-1399.
24. Tanaka, H., Baba, M., Saito, S., Miyasaka, T., Takashima, H., Sekiya, K., Ubasawa, M., Nitta, I., Walker, R.T., Nakashima, H. and De Clercq, E. (1991) "Specific anti-HIV-1 acyclonucleosides which cannot be phosphorylated: synthesis of some deoxy analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio) thymine", J. Med. Chem. 34, 1508-1511.
25. Tanaka, H., Baba, M., Hayakawa, H., Haraguchi, K., Miyasaka, T., Ubasawa, M., Takashima, H., Sekiya, K., Nitta, I., Walker, R.T. and De Clercq, E. (1991) "Lithiation of uracil nucleosides and its application to the synthesis of a new class of anti-HIV-1 acyclonucleosides", Nucleosides Nucleotides 10, 397-400.
26. Pauwels, R., Andries, K., Debyser, Z., Kukla, M.J., Schols, D., Breslin, H.J., Woestenborghs, R., Desmyter, J., Janssen, M.A.C., De Clercq, E. and Janssen, P.A. (1994) "New tetrahydroimidazo[4,5,1-jk][1,4]-benzodiazepin- 2(1H)-one and -thione derivatives are potent inhibitors of human immunodeficiency virus type 1 replication and are synergistic with 2′,3′-dideoxynucleoside analogs", J. Antimicrob. Agents Chemother. 38, 2863-2870.
27. Clark, M., Cramer, R.D. III and Van, O.N. (1989) "The Tripos force field", J. Comput. Chem. 10, 982-1012.
28. Weiner, S.J., Kollman, P.A., Case, D.A., Singh, U.C., Ghio, C., Alagona, G., Profeta, S.J. and Weiner, P. (1984) "A new force field for molecular mechanical simulation of nucleic acids and proteins", J. Am. Chem. Soc. 106, 765-784.
29. Morris, G.M., Goodsell, D.S., Halliday, R.S., Huey, R., Hart, W.E., Belew, R.K. and Olson, A.J. (1998) "Automated docking using a Lamarckian genetic algorithm and empirical binding free energy function", J. Comput. Chem. 19, 1639-1662.
30. Morris, G.M., Goodsell, D.S., Huey, R. and Olson, A.J. (1996) "Distributed automated docking of flexible ligands to proteins: parallel applications of AutoDock 2.4", J. Comput.-Aided Mol. Des. 10, 293-304.
31. 2-guided region selection for comparative molecular field analysis (CoMFA): a simple method to achieve consistent results", J. Med. Chem. 38, 1060-1066.
32. SYBYL [Computer Program] (2001) Version 6.8, St. Louis (MO): Tripos Associates Inc.
33. Clark, M. and Cramer, R.D. III (1993) "The probability of chance correlation using partial least squares (PLS)", Quant. Struct. Act. Relat. 12, 137-145.
34. Klebe, G., Abraham, U. and Mietzner, T. (1994) "Molecular similarity indices in a Comparative Analysis (CoMSIA) of drug molecules to correlate and predict their biological activity", J. Med. Chem. 37, 4130-4146.
35. Böhm, M., Stürzebecher, J. and Klebe, G. (1999) "3D QSAR analyses using CoMFA and CoMSIA to elucidate selectivity differences of inhibitors binding to trypsin, thrombin and factor Xa", J. Med. Chem. 42, 458-477.
36. Leach, A.L. (2001) Molecular Modelling Principles and Applications (Henry Ling Ltd. Press, London), pp 695-702.
37. Hopkins, A.L., Ren, J.S., Tanaka, H., Baba, M., Okamato, M., Stuart, D.I. and Stammers, K. (1999) "Design of MKC-442 (emivirine) analogues with improved activity against drug-resistant HIV mutants", J. Med. Chem. 42, 4500-4505.
38. Garg, R., Gupta, S.P., Gao, H., Babu, M.S., Debnath, A.K. and Hansch, C. (1999) "Comparative quantitative structure-activity relationship studies on anti-HIV drugs", Chem. Rev. 99, 3525-3602.
39. Rizzo, R.C., Wang, D.P., Tirado, R.J. and Jorgensen, W.L. (2000) "Validation of a model for the complex of HIV-1 reverse transcriptase with sustiva through computation of resistance profiles", J. Am. Chem. Soc. 122, 12898-12900.